Evaluation of microRNAs-29a, 92a and 145 in colorectal carcinoma as candidate diagnostic markers: An Egyptian pilot study

Clinics and Research in Hepatology and Gastroenterology

Volumn 39, Issue 4, 2015, Pages 508-515

  Ramzy, Iman ^a   Hasaballah, Maha ^a   Marzaban, Raghda ^a   Shaker, Olfat ^a   Soliman, Zienab A ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 145; MICRORNA 29A; MICRORNA 92A; UNCLASSIFIED DRUG; TUMOR MARKER;

ADENOMATOUS POLYP; ADULT; ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DOWN REGULATION; EGYPTIAN; FEMALE; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; BLOOD; CARCINOMA; CASE CONTROL STUDY; COLORECTAL NEOPLASMS; MIDDLE AGED; PRECANCEROUS CONDITIONS;

ADENOMATOUS POLYPS; BIOMARKERS, TUMOR; CARCINOMA; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; DOWN-REGULATION; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MICRORNAS; MIDDLE AGED; PILOT PROJECTS; PRECANCEROUS CONDITIONS; UP-REGULATION;

EID: 84940899092     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2014.12.008     Document Type: Article

References (43)

1. Jemal A., Bray F., Center M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90.
2. Zakaria M., Hashem A., Abdelbary M., Amer A., Serag K., Lashin S., et al. The pattern of colonic diseases in Egypt: a colonoscopic study. Arab J Gastroenterol 2006, 7:53-58.
3. Janga S.C., Vallabhaneni S. MicroRNAs as post-transcriptional machines and their interplay with cellular networks. Adv Exp Med Biol 2011, 722:59-74.
4. Esquela-Kerscher A., Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006, 6(4):259-269.
5. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009, 10(10):704-714.
6. Wang Y., Lee C.G.L. MicroRNA and cancer - focus on apoptosis. J Cell Mol Med 2009, 13(1):12-23.
7. Schee K., Fodstad Ø., Flatmark K. MicroRNAs as biomarkers in colorectal cancer. Am J Pathol 2010, 177(4):1592-1599.
8. Corté H., Manceau G., Blons H., Laurent-Puig P. MicroRNA and colorectal cancer. Dig. Liver Dis 2012, 44(3):195-200.
9. Tang W., Zhu Y., Gao J., Fu J., Liu C., Liu Y., et al. MicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E-cadherin via KLF4. Br J Cancer 2014, 110(2):450-458. [Nature Publishing Group].
10. John B., Enright A.J., Aravin A., Tuschl T., Sander C., Marks D.S. Human MicroRNA targets. PLoS Biol 2004, 2(11):e363. [Public Library of Science].
11. Zhang G., Zhou H., Xiao H., Liu Z., Tian H., Zhou T. MicroRNA-92a functions as an oncogene in colorectal cancer by targeting PTE. Dig Dis Sci 2014, 59(1):98-107.
12. Feng Y., Zhu J., Ou C., Deng Z., Chen M., Huang W., et al. MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1. Br J Cancer 2014, 110(9):2300-2309.
13. Ma Y., Reynolds L.E., Li A., Stevenson R.P., Hodivala-Dilke K.M., Yamashiro S., et al. Fascin 1 is dispensable for developmental and tumour angiogenesis. Biol Open 2013, 2(11):1187-1191.
14. Suzuki H.I., Yamagata K., Sugimoto K., Iwamoto T., Kato S., Miyazono K. Modulation of microRNA processing by p53. Nature 2009, 460(7254):529-533.
15. Dong Y., Wu W.K.K., Wu C.W., Sung J.J.Y., Yu J., Ng S.S.M. MicroRNA dysregulation in colorectal cancer: a clinical perspective. Br J Cancer 2011, 104(6):893-898. [Cancer Research UK].
16. AJCC Cancer Staging Handbook 2010, 173-206. Springer, Chicago, IL. 7th ed. S.B. Edge, D.R. Byrd, C.C. Comptom (Eds.).
17. Gado A., Ebeid B., Abdelmohsen A., Axon A. Colorectal cancer in Egypt is commoner in young people: Is this cause for alarm?. Alexandria J Med 2014, 50(3):197-201.
18. Zeeneldin A., Saber M., Seif El-din I., Frag S. Colorectal carcinoma in gharbiah district; Egypt: Comparison between the elderly and non-elderly. J Solid Tumors 2014, 2(3):13-23.
19. Hrašovec S., Glavač D. MicroRNAs as novel biomarkers in colorectal cancer. Front Genet 2012, 3:180.
20. Bonfrate L., Altomare D., Di Lena M., Travaglio E., Rotelli M., De Luca A., et al. MicroRNA in colorectal cancer: new perspectives for diagnosis, prognosis and treatment. J Gastrointest Liver Dis 2013, 22:311-320.
21. Liu M., Chen H. The role of microRNAs in colorectal cancer. J Genet Genomics 2010, 37(6):347-358.
22. Schetter A.J., Okayama H., Harris C.C. The role of microRNAs in colorectal cancer. Cancer J 2012, 18(3):244-252.
23. Tokarz P., Blasiak J. The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment. Acta Biochim Pol 2012, 59(4):467-474.
24. Veruttipong D., Soliman A., Gilbert S., Blachley T., Hablas A., Ramadan M., et al. Age distribution, polyps and rectal cancer in the Egyptian population-based cancer registry. World J Gastroenterol 2012, 18(30):3997-4003.
25. La Vecchia C. Fecal occult blood screening for colorectal cancer: open issues. Ann Oncol 2002, 13(1):31-34.
26. Walsh J.M.E., Terdiman J.P. Colorectal Cancer Screening. JAMA 2003, 289(10):1288. [American Medical Association].
27. Khafagy W., El-Ghazaly M., E-Shobaky M.T., Khafagy M. Das kolorektale Karzinom in Ägypten-Unterschiede zu anderen Ländern?. Coloproctology 2000, 22(3):109.
28. O'Connell J.B., Maggard M.A., Liu J.H., Etzioni D.A., Livingston E.H., Ko C.Y. Do young colon cancer patients have worse outcomes?. World J Surg 2004, 28(6):558-562.
29. Pendergrass C.J., Edelstein D.L., Hylind L.M., Phillips B.T., Iacobuzio-Donahue C., Romans K., et al. Occurrence of colorectal adenomas in younger adults: an epidemiologic necropsy study. Clin Gastroenterol Hepatol 2008, 6(9):1011-1015.
30. Winawer S.J., Fletcher R.H., Miller L., Godlee F., Stolar M.H., Mulrow C.D., et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997, 112(2):594-642.
31. Esmat S., El Nady M., Elfekki M., Elsherif Y., Naga M. Epidemiological and clinical characteristics of inflammatory bowel diseases in Cairo. Egypt World J Gastroenterol 2014, 20(3):814-821.
32. Itzkowitz S.H., Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 2004, 126(6):1634-1648.
33. Faltejskova P., Bocanek O., Sachlova M., Svoboda M., Kiss I., Vyzula R., et al. Circulating miR-17-3p, miR-29a, miR-92a and miR-135b in serum: evidence against their usage as biomarkers in colorectal cancer. Cancer Biomarkers 2012, 12(4):199-204.
34. Huang Z., Huang D., Ni S., Peng Z., Sheng W., Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010, 127(1):118-126.
35. Brunet Vega A., Pericay C., Moya I., Ferrer A., Dotor E., Pisa A., et al. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers. Oncol Rep 2013, 30(1):320-326.
36. Wang L.-G., Gu J. Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. Cancer Epidemiol 2012, 36(1):e61-e67.
37. Ng E.K.O., Chong W.W.S., Jin H., Lam E.K.Y., Shin V.Y., Yu J., et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut. 2009, 58(10):1375-1381.
38. Yang X., Zeng Z., Hou Y., Yuan T., Gao C., Jia W. MicroRNA-92a as a potential biomarker in diagnosis of colorectal cancer: a systematic review and meta-analysis. PLoS One 2014, 9(2):e88745. [Public Library of Science].
39. Luo X., Burwinkel B., Tao S., Brenner H. MicroRNA signatures: novel biomarker for colorectal cancer?. Cancer Epidemiol Biomarkers Prev 2011, 20(7):1272-1286.
40. Wu C.W., Ng S.S.M., Dong Y.J., Ng S.C., Leung W.W., Lee C.W., et al. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut 2012, 61(5):739-745.
41. Michael M., O'Connor S., van Holst Pellekaan N., Young G., James R. Reduced accumulation of specic microRNAs in colorectal neoplasia. Mol Cancer Res 2003, 1:882-891.
42. Li J.-M., Zhao R.-H., Li S.-T., Xie C.-X., Jiang H.-H., Ding W.-J., et al. Downregulation of fecal miR-143 and miR-145 as potential markers for colorectal cancer. Saudi Med J 2012, 33(1):24-29.
43. Ma Y., Zhang P., Yang J., Liu Z., Yang Z., Qin H. Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation. Int J Cancer 2012, 130(9):2077-2087.